FAM185A
geneOn this page
Also known as MGC35361
Summary
FAM185A (family with sequence similarity 185 member A, HGNC:22412) is a protein-coding gene on chromosome 7q22.1, encoding Protein FAM185A (Q8N0U4).
Located in mitochondrion.
Source: NCBI Gene 222234 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 66 total
- MANE Select transcript:
NM_001145268
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22412 |
| Approved symbol | FAM185A |
| Name | family with sequence similarity 185 member A |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC35361 |
| Ensembl gene | ENSG00000222011 |
| Ensembl biotype | protein_coding |
| Entrez | 222234 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 10 protein_coding, 3 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000409231, ENST00000413034, ENST00000418198, ENST00000420217, ENST00000442873, ENST00000481697, ENST00000487807, ENST00000496790, ENST00000880453, ENST00000880454, ENST00000880455, ENST00000880456, ENST00000880457, ENST00000950231, ENST00000950232
RefSeq mRNA: 3 — MANE Select: NM_001145268
NM_001145268, NM_001145269, NM_001350987
CCDS: CCDS47676, CCDS47677
Canonical transcript exons
ENST00000413034 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001867186 | 102808290 | 102809225 |
| ENSE00001933049 | 102748999 | 102749658 |
| ENSE00003467076 | 102787335 | 102787469 |
| ENSE00003523363 | 102761273 | 102761411 |
| ENSE00003557868 | 102757854 | 102757946 |
| ENSE00003574112 | 102772409 | 102772450 |
| ENSE00003632688 | 102751692 | 102751801 |
| ENSE00003685690 | 102777253 | 102777348 |
Expression profiles
Bgee: expression breadth ubiquitous, 138 present calls, max score 90.52.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.5852 / max 27.9844, expressed in 1241 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 80259 | 2.5852 | 1241 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| quadriceps femoris | UBERON:0001377 | 90.52 | silver quality |
| corpus callosum | UBERON:0002336 | 89.16 | gold quality |
| calcaneal tendon | UBERON:0003701 | 87.41 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.24 | gold quality |
| colonic epithelium | UBERON:0000397 | 82.67 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 82.58 | gold quality |
| cerebellar vermis | UBERON:0004720 | 82.05 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.55 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 80.68 | gold quality |
| muscle tissue | UBERON:0002385 | 80.52 | gold quality |
| muscle of leg | UBERON:0001383 | 80.13 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.13 | gold quality |
| gastrocnemius | UBERON:0001388 | 79.71 | gold quality |
| endometrium | UBERON:0001295 | 79.46 | gold quality |
| sural nerve | UBERON:0015488 | 79.07 | gold quality |
| liver | UBERON:0002107 | 78.43 | gold quality |
| ovary | UBERON:0000992 | 77.70 | gold quality |
| left ovary | UBERON:0002119 | 77.43 | gold quality |
| mucosa of stomach | UBERON:0001199 | 77.23 | gold quality |
| ventricular zone | UBERON:0003053 | 77.17 | gold quality |
| right lobe of liver | UBERON:0001114 | 77.12 | gold quality |
| popliteal artery | UBERON:0002250 | 77.05 | gold quality |
| tibial artery | UBERON:0007610 | 77.05 | gold quality |
| uterine cervix | UBERON:0000002 | 77.04 | gold quality |
| tonsil | UBERON:0002372 | 77.01 | gold quality |
| stomach | UBERON:0000945 | 76.94 | gold quality |
| right ovary | UBERON:0002118 | 76.92 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 76.90 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 76.62 | gold quality |
| lower esophagus | UBERON:0013473 | 76.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.30 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting FAM185A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-298 | 99.63 | 67.56 | 1916 |
| HSA-MIR-1287-3P | 99.63 | 66.93 | 492 |
| HSA-MIR-12122 | 99.56 | 69.33 | 1672 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-6083 | 99.47 | 68.73 | 2393 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-5580-5P | 99.38 | 66.96 | 1139 |
| HSA-MIR-6744-3P | 99.22 | 64.41 | 972 |
| HSA-MIR-4528 | 99.18 | 69.77 | 1936 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-4757-5P | 99.12 | 64.51 | 981 |
| HSA-MIR-6770-5P | 98.97 | 66.76 | 1853 |
| HSA-MIR-936 | 98.87 | 70.51 | 1124 |
| HSA-MIR-5590-5P | 98.81 | 68.78 | 969 |
| HSA-MIR-6501-3P | 98.71 | 67.45 | 1480 |
| HSA-MIR-1537-5P | 98.70 | 68.33 | 999 |
| HSA-MIR-496 | 98.66 | 69.80 | 931 |
| HSA-MIR-649 | 97.96 | 67.21 | 704 |
| HSA-MIR-483-3P | 97.77 | 64.95 | 731 |
| HSA-MIR-1226-3P | 97.51 | 66.32 | 1063 |
| HSA-MIR-1233-3P | 96.81 | 65.44 | 573 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam185a | ENSDARG00000019142 |
| mus_musculus | Fam185a | ENSMUSG00000047221 |
| rattus_norvegicus | AABR07059232.1 | ENSRNOG00000048371 |
| drosophila_melanogaster | CG8187 | FBGN0034027 |
Protein
Protein identifiers
Protein FAM185A — Q8N0U4 (reviewed: Q8N0U4)
All UniProt accessions (3): C9JFL0, Q8N0U4, F8WFC0
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N0U4-1 | 1 | yes |
| Q8N0U4-2 | 2 | |
| Q8N0U4-3 | 3 |
RefSeq proteins (3): NP_001138740, NP_001138741, NP_001337916 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025164 | Toastrack_DUF4097 | Domain |
Pfam: PF13349
UniProt features (6 total): splice variant 2, sequence variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N0U4-F1 | 78.62 | 0.50 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 73 (showing top):
AGGCACT_MIR5153P, CUI_TCF21_TARGETS_2_UP, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, LI_INDUCED_T_TO_NATURAL_KILLER_UP, KATSANOU_ELAVL1_TARGETS_DN, FEV_TARGET_GENES, FOXJ2_TARGET_GENES, HOXB6_TARGET_GENES, RYBP_TARGET_GENES, ZNF223_TARGET_GENES, GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN, GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN, MIR4481, MIR496
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
424 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM185A | A0A0J9YYB4 | A0A0J9YYB4 | 599 |
| FAM185A | FBXL13 | Q8NEE6 | 532 |
| FAM185A | ZBTB45 | Q96K62 | 518 |
| FAM185A | DISP2 | A7MBM2 | 506 |
| FAM185A | TMEM134 | Q9H6X4 | 499 |
| FAM185A | SLC35F3 | Q8IY50 | 479 |
| FAM185A | NOL4 | O94818 | 462 |
| FAM185A | WDR70 | Q9NW82 | 409 |
| FAM185A | ARHGAP15 | Q53QZ3 | 399 |
| FAM185A | GJA9 | P57773 | 398 |
| FAM185A | SURF6 | O75683 | 392 |
| FAM185A | ENTPD7 | Q9NQZ7 | 389 |
| FAM185A | SEC14L4 | Q9UDX3 | 380 |
| FAM185A | LYPLAL1 | Q5VWZ2 | 378 |
| FAM185A | COLQ | Q9Y215 | 376 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HGS | FAM185A | psi-mi:“MI:0915”(physical association) | 0.560 |
| NDUFV2 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.530 |
| FAM185A | NOTCH1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NDUFV3 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM55 | FAM185A | psi-mi:“MI:0915”(physical association) | 0.000 |
| HGS | FAM185A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): FAM185A (Two-hybrid), FAM185A (Two-hybrid), FAM185A (Two-hybrid), FAM185A (Two-hybrid), FAM185A (Affinity Capture-MS), FAM185A (Affinity Capture-MS), FAM185A (Co-fractionation), FAM185A (Co-fractionation), FAM185A (Co-fractionation), FAM185A (Co-fractionation)
ESM2 similar proteins: A0JMU5, A1A5V9, A4D1P6, A4IGH4, A7E3S5, A7Z052, B2RYI0, D3ZEY4, E7FCP8, O08721, O08722, O46510, P49222, P52824, P57081, Q2EMV9, Q2HJE1, Q32N48, Q32PH0, Q3TIU4, Q3UY23, Q52L34, Q5FVB6, Q5RB07, Q5XFW6, Q5ZLL7, Q6AXQ5, Q6P5E8, Q6TEN6, Q6ZN44, Q6ZPG2, Q7T2Z5, Q7TMQ7, Q7TPD2, Q7ZY78, Q8BUI3, Q8IZJ1, Q8K1S3, Q8K1S4, Q8K337
Diamond homologs: Q7TPD2, Q8N0U4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
66 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 57 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2018 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:102749670:G:GT | donor_gain | 1.0000 |
| 7:102757945:GT:G | donor_gain | 1.0000 |
| 7:102761400:G:GT | donor_gain | 1.0000 |
| 7:102777247:TCCTA:T | acceptor_loss | 1.0000 |
| 7:102777248:CCTA:C | acceptor_loss | 1.0000 |
| 7:102777249:CTAG:C | acceptor_loss | 1.0000 |
| 7:102777250:TA:T | acceptor_loss | 1.0000 |
| 7:102777251:A:AG | acceptor_gain | 1.0000 |
| 7:102777251:AG:A | acceptor_loss | 1.0000 |
| 7:102777252:G:GG | acceptor_gain | 1.0000 |
| 7:102777252:GATTC:G | acceptor_gain | 1.0000 |
| 7:102777345:AAAGG:A | donor_loss | 1.0000 |
| 7:102777346:AAGGT:A | donor_loss | 1.0000 |
| 7:102777347:AGG:A | donor_loss | 1.0000 |
| 7:102777348:GGTT:G | donor_loss | 1.0000 |
| 7:102777349:G:A | donor_loss | 1.0000 |
| 7:102778709:ACT:A | acceptor_gain | 1.0000 |
| 7:102778709:ACTG:A | acceptor_gain | 1.0000 |
| 7:102778711:T:A | acceptor_gain | 1.0000 |
| 7:102778712:G:A | acceptor_gain | 1.0000 |
| 7:102749651:G:GT | donor_gain | 0.9900 |
| 7:102749663:GTGAA:G | donor_gain | 0.9900 |
| 7:102749665:G:GT | donor_gain | 0.9900 |
| 7:102749682:GGTT:G | donor_gain | 0.9900 |
| 7:102749725:TCG:T | donor_gain | 0.9900 |
| 7:102751687:TCTA:T | acceptor_loss | 0.9900 |
| 7:102751688:CTA:C | acceptor_loss | 0.9900 |
| 7:102751688:CTAGG:C | acceptor_gain | 0.9900 |
| 7:102751689:TA:T | acceptor_loss | 0.9900 |
| 7:102751689:TAGG:T | acceptor_gain | 0.9900 |
AlphaMissense
2515 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:102787347:T:A | V315D | 0.971 |
| 7:102761292:T:C | L225P | 0.970 |
| 7:102808373:T:A | W384R | 0.970 |
| 7:102808373:T:C | W384R | 0.970 |
| 7:102761297:G:A | G227R | 0.964 |
| 7:102761297:G:C | G227R | 0.964 |
| 7:102751781:A:C | S181R | 0.963 |
| 7:102751783:T:A | S181R | 0.963 |
| 7:102751783:T:G | S181R | 0.963 |
| 7:102757870:T:A | V193D | 0.957 |
| 7:102757896:T:C | C202R | 0.957 |
| 7:102808375:G:C | W384C | 0.955 |
| 7:102808375:G:T | W384C | 0.955 |
| 7:102808326:T:C | I368T | 0.954 |
| 7:102751801:G:C | K187N | 0.951 |
| 7:102751801:G:T | K187N | 0.951 |
| 7:102808331:G:C | A370P | 0.951 |
| 7:102761298:G:A | G227E | 0.950 |
| 7:102777334:T:C | L306S | 0.950 |
| 7:102777271:T:C | L285P | 0.949 |
| 7:102749515:T:A | V103D | 0.948 |
| 7:102761277:T:A | V220E | 0.946 |
| 7:102761349:T:C | L244P | 0.945 |
| 7:102749599:T:A | I131N | 0.942 |
| 7:102761292:T:G | L225R | 0.940 |
| 7:102808332:C:A | A370D | 0.940 |
| 7:102772426:A:C | S271R | 0.938 |
| 7:102772428:C:A | S271R | 0.938 |
| 7:102772428:C:G | S271R | 0.938 |
| 7:102749655:T:C | F150L | 0.936 |
dbSNP variants (sampled 300 via entrez): RS1000067206 (7:102816734 C>T), RS1000145710 (7:102837730 A>G), RS1000158398 (7:102842244 C>T), RS1000210081 (7:102766771 C>T), RS1000348060 (7:102801886 C>G,T), RS1000360534 (7:102782337 A>G), RS1000394658 (7:102782605 G>A), RS1000397046 (7:102845226 C>T), RS1000494154 (7:102830410 A>G), RS1000526735 (7:102788039 A>C), RS1000538372 (7:102836357 C>G,T), RS1000568989 (7:102775475 C>T), RS1000591720 (7:102835893 G>A), RS1000628661 (7:102837189 C>A,T), RS1000700648 (7:102843350 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_605 | Obesity-related traits | 2.000000e-07 |
| GCST003429_6 | Morning vs. evening chronotype | 6.000000e-09 |
| GCST006479_111 | Diverticular disease | 4.000000e-14 |
| GCST007565_114 | Morning person | 4.000000e-36 |
| GCST007576_16 | Chronotype | 4.000000e-36 |
| GCST90014033_83 | Haemorrhoidal disease | 6.000000e-18 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005190 | urinary nitrogen measurement |
| EFO:0009959 | diverticular disease |
| EFO:0008328 | chronotype measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation, affects cotreatment, decreases expression, increases abundance | 2 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| lead acetate | decreases expression | 1 |
| sodium arsenite | affects cotreatment, decreases expression, increases abundance | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| avobenzone | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | increases expression, affects cotreatment | 1 |
| Air Pollutants | decreases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Manganese | affects cotreatment, decreases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hemorrhoid